Skip to content

Akebia Therapeutics Inc Sustainability Reports

Akebia Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with kidney disease.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300CBQEHMKEEGNX42

FIGI: BBG001T922S9

7 reports from 2014 to 2025